Deletion of IFN-γ reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors

Journal of Interferon and Cytokine Research

Volumn 23, Issue 1, 2003, Pages 13-23

  Sharma, Raghubir P ^a   He, Quanren ^a   Johnson, Victor J ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; FUMONISIN B1; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; SPHINGANINE; SPHINGOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL DIVISION; CYTOKINES; FUMONISINS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-12; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; EQUIDAE; SPHINGIODEA; SUIDAE;

EID: 0037227992     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900360520414     Document Type: Article

References (31)

1. MARASAS, W.F.O. (2001). Discovery and occurrence of the fumonisins: a historical perspective. Environ. Health Perspect. 109 (Suppl. 2), 239-243.
2. RILEY, R.T., VOSS, K.A., NORRED, W.P., SHARMA, R.P., WANG, E., and MERRILL, A.H. (1998). Fumonisins: mechanisms of mycotoxicity. Rev. Med. Vet. 149, 617-626.
3. 1 isolated from Fusarium moniliforme. J. Vet. Res. 55, 197-203.
4. 1, a toxic matabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 2, 217-221.
5. VOSS, K.A., RILEY, R.T., NORRED, W.P., BACON, C.W., MEREDITH, F.I. HOWARD, P.C., PLATTNER, R.D., COLLINS, T.F.X., HANSON, D,K., and PORTER, J.K. (2001). An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ. Health Perspect. 109(Suppl. 2), 259-266.
6. 1 mice. Environ. Health Perspect. 109(Suppl. 2), 277-282.
7. RILEY, R.T., WANG, E., SCHROEDER, J.J., SMITH, E.R., PLATTNER, R.D., ABBAS, H., YOO, H.S., and MERRILL, A.H. (1996). Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins 4, 3-15.
8. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J. Biochem. Mol. Toxicol. 12, 281-289.
9. 1 toxicity. J. Pharmacol. Exp. Ther. 285, 317-324.
10. SHARMA, R.P., BHANDARI, N., RILEY, R.T., VOSS, K.A., and MEREDITH, F.I. (2000). Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor. Toxicology 143, 183-194.
11. SHARMA, R.P., BHANDARI, N., HE, Q., RILEY, R.T., and VOSS, K.A. (2000). Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. Toxicology 159, 69-79.
12. 1 hepatotoxicity in BALB/c mice. Toxicology 165, 195-204.
13. BHANDARI, N., BROWN, C.C., and SHARMA, R.P. (2002). Fumonisin-induced localized activation of cytokine network in mouse liver. Food Chem. Toxicol. 40, 23-31.
14. 1. Chem-Biol. Interact. 139, 317-331.
15. DALTON, D.K., PITTS-MEEK, S., KESHAV, S., FIGARI, I.S., BRADLEY, A., and STEWART, T.A. (1993). Multiple defects of immune cell function in mice with disrupted interferon γ genes. Science 259, 1739-1742.
16. SHARMA, R.P., HE, Q., MEREDITH, F.I, RILEY, R.T., and VOSS, K.A. (2002). Paradoxical role of tumor necrosis factor alpha in fumonisin-induced hepatotoxicity in mice. Toxicology 180, 221-232.
17. 1. J. Comp. Pathol. 117, 371-381.
18. 1-induced tumor necrosis factor α and interferon γ in mice. Comp. Biochem. Physiol. C 131, 113-122.
19. 1-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. Toxicology 172, 81-92.
20. MEMON, R.A., HOLLERAN, W.M., MOSER, A.H., SEKI, T., UCHIDA, Y., FULLER, J., SHIGENAGA, J.K., GRUNFELD, C., and FEINGOLD, K.R. (1998). Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 18, 1257-1265.
21. 1-induced apoptosis. Environ. Health Perspect. 109(Suppl. 2), 315-320.
22. KAPLAN, D.H., and SCHREIBER, R.D. (1999). Interferons: biochemistry and biology. In: The Cytokine Network and Immune Functions. J. Thèze (ed.) Oxford: Oxford University Press, pp. 111-124.
23. OGASAWARA, K., TAKEDA, K., HASHIMOTO, W., SATOH, M., OKUYAMA, R., YANAI, N., OBINATA, M., KUMAGAI, K., TAKADA, H., HIRAIDE, H., and SEKI, S. (1998). Involvement of NK1 + T cells and their IFN-γ production in the generalized Shwartzman reaction. J. Immunol. 160, 3522-3527.
24. OZMAN. L., PERICIN, M., HAKIMI, J., CHIZZONITE, R.A., WYSOCKA, M., TRINCHIERI, G., GATELY, M., and GAROTTA, G. (1994). Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180, 907-915.
25. XING, Z., ZGANIACZ, A., and SANTOSUOSSO, M. (2000). Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide front macrophages via IFN-γ induction. J. Leukocyte Biol. 68, 897-902.
26. -/- mice. J. Immunol. 159, 1418-1428.
27. OKAMOTO, T., YAMAMURA, K.-I., and HINO, O. (1999). The mouse interferon-γ transgene chronic hepatitis model. Int. J. Mol. Med. 3, 517-520.
28. RILEY, R.T., VOSS, K.A., NORRED, W.P., BACON, C.W., MEREDITH, M.I., and SHARMA, R.P. (1999). Serine palmitoyl transferase inhibition reverses antiproliferative effects of ceramide synthase inhibition in cultured renal cells and suppresses free sphingoid base accumulation in kidney of BALB/c mice. Environ. Toxicol. Pharmacol. 7, 109-118.
29. 1): a model for reducing fumonisin-induced nephrotoxicity in vivo. Pharmacol. Toxicol. 90, 268-277.
30. RILEY, R.T., ENONGENE, E., VOSS, K.A., NORRED, W.P., MEREDITH, F.I., SHARMA, R.P., WILLIAMS, D., SPITSBERGEN, J., WILLIAMS, D.E., CARLSON, D.B., and MERRILL, A.H. (2001). Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109(Suppl. 2), 301-308.
31. BAUDINO, T.A., and CLEVELAND, J.L. (2001). The max network gone mad. Mol. Cell. Biol. 21, 691-702.